Search Results - "Buglioni S"

56P The prognostic role of KRAS mutations in patients with early-stage lung adenocarcinoma after robotic lobectomy and systematic lymphadenectomy.

Authors: Gallina, F.T. Marinelli, D. Forcella, D. et al.

Source: Annals of Oncology. 2022 Supplement 8, Vol. 33, pS1400-S1401. 2p.

KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma.

Authors: Gallina, F.T. Marinelli, D. Melis, E. et al.

Source: Lung Cancer (01695002). Jul2023, Vol. 181, pN.PAG-N.PAG. 1p.

1048P Molecular predictors of immunotherapy efficacy in lung squamous-cell carcinoma (LSCC): Results from the randomized prospective SQUINT trial.

Authors: Cappuzzo, F. Delmonte, A. Landi, L. et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1033-S1033. 1p.

517 - Enhancement of doxorubicin cytotoxicity by histone deacetylase inhibition in human sarcoma cells.

Authors: Tupone, M.G. Trisciuoglio, D. Desideri, M. et al.

Source: European Journal of Cancer. Jul2016 Supplement 1, Vol. 61, pS111-S111. 1p.

518 - Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells.

Authors: Di Martile, M. Desideri, M. De Luca, T. et al.

Source: European Journal of Cancer. Jul2016 Supplement 1, Vol. 61, pS111-S112. 1p.

Kirsten Rat Sarcoma Virus Mutations Effect On Tumor Doubling Time And Prognosis Of Solid Dominant Stage I Lung Adenocarcinoma.

Authors: Tajè R Ambrogi V Tacconi F et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2025 May; Vol. 26 (3), pp. 210-220.e1. Date of Electronic Publication: 2025 Jan 09.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort.

Authors: Tajè R Gallina FT Caterino M et al.

Source: BMC cancer [BMC Cancer] 2025 Apr 09; Vol. 25 (1), pp. 647. Date of Electronic Publication: 2025 Apr 09.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.

Authors: Petti E Di Vito S Dinami R et al.

Source: Cell death & disease [Cell Death Dis] 2025 Mar 30; Vol. 16 (1), pp. 224. Date of Electronic Publication: 2025 Mar 30.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancer.

Authors: Malapelle U Buglioni S Castellano I et al.

Source: Pathologica [Pathologica] 2025 Dec; Vol. 117 (6), pp. 546-558.

Publication Type: Journal Article; Review

Journal Info: Publisher: Pacini Editore SpA Country of Publication: Italy NLM ID: 0401123 Publication Model: Print Cited Medium: Internet ISSN: 1591-951X (Electronic) Linking ISSN: 00312983 NLM ISO Abbreviation: Pathologica Subsets: MEDLINE

TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma.

Authors: Gallina FT Marinelli D Tajè R et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Sep 09; Vol. 227, pp. 115622. Date of Electronic Publication: 2025 Jul 10.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Identification of a set of genes potentially responsible for resistance to ferroptosis in lung adenocarcinoma cancer stem cells.

Authors: Ascenzi F Esposito A Bruschini S et al.

Source: Cell death & disease [Cell Death Dis] 2024 Apr 29; Vol. 15 (4), pp. 303. Date of Electronic Publication: 2024 Apr 29.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer.

Authors: Ricciuti B Fusco F Cooper A et al.

Source: JAMA oncology [JAMA Oncol] 2025 Jul 01; Vol. 11 (7), pp. 735-741.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

A decalogue of Molecular Tumor Board (MTB) recommendations from the CAN.HEAL Consortium.

Authors: Ciliberto G De Maria R Giacomini P et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jun 03; Vol. 222, pp. 115433. Date of Electronic Publication: 2025 Apr 14.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Part III - Post-analytical phase.

Authors: Buglioni S Seminati D Bruno R et al.

Source: Pathologica [Pathologica] 2025 May 09; Vol. 117 (2(Suppl.1)), pp. S36-S62.

Publication Type: Guideline; Journal Article

Journal Info: Publisher: Pacini Editore SpA Country of Publication: Italy NLM ID: 0401123 Publication Model: Print Cited Medium: Internet ISSN: 1591-951X (Electronic) Linking ISSN: 00312983 NLM ISO Abbreviation: Pathologica Subsets: MEDLINE

Part II - Analytical phase.

Authors: Guerini-Rocco E Venetis K Bessi S et al.

Source: Pathologica [Pathologica] 2025 May 09; Vol. 117 (2(Suppl.1)), pp. S18-S35.

Publication Type: Guideline; Journal Article

Journal Info: Publisher: Pacini Editore SpA Country of Publication: Italy NLM ID: 0401123 Publication Model: Print Cited Medium: Internet ISSN: 1591-951X (Electronic) Linking ISSN: 00312983 NLM ISO Abbreviation: Pathologica Subsets: MEDLINE

Part I - Pre-analytical phase.

Authors: Marchiò C Berrino E Scarpino S et al.

Source: Pathologica [Pathologica] 2025 May 09; Vol. 117 (2(Suppl.1)), pp. S5-S17.

Publication Type: Guideline; Journal Article

Journal Info: Publisher: Pacini Editore SpA Country of Publication: Italy NLM ID: 0401123 Publication Model: Print Cited Medium: Internet ISSN: 1591-951X (Electronic) Linking ISSN: 00312983 NLM ISO Abbreviation: Pathologica Subsets: MEDLINE

BRAF mutation and neoadjuvant chemo-immunotherapy, is it worthwhile?

Authors: Gallina FT Cecere FL Bergomi S et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 May; Vol. 203, pp. 108514. Date of Electronic Publication: 2025 Apr 03.

Publication Type: Letter

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE; In Process

Impact and Reproducibility of In-House Targeted Next-Generation Sequencing Biomarker Testing in Non-Small-Cell Lung Cancer: An Italian Multi-Institutional Experience.

Authors: Rapa I Bertola F Roversi G et al.

Source: The Journal of molecular diagnostics : JMD [J Mol Diagn] 2025 May; Vol. 27 (5), pp. 371-382. Date of Electronic Publication: 2025 Feb 27.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE

MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Randomized, Prospective SQUINT Trial.

Authors: Cappuzzo F Ricciuti B Delmonte A et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Mar 17; Vol. 31 (6), pp. 1027-1036.

Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify^® Mutation Profiler.

Authors: Pepe F Russo G Barraco N et al.

Source: Oncology and therapy [Oncol Ther] 2025 Mar; Vol. 13 (1), pp. 115-130. Date of Electronic Publication: 2024 Nov 28.

Publication Type: Journal Article

Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101677510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2366-1089 (Electronic) Linking ISSN: 23661089 NLM ISO Abbreviation: Oncol Ther Subsets: PubMed not MEDLINE